In my latest blog post at bkoffman.blogspot.com, Dr. Byrd discusses a promising drug that could help some of the toughest CLL patients that will probably never become commercially available. We talk about why this is happening and what it means for those of us with CLL.
ASH 2013: Dr. Byrd Discusses Dinaciclib and th... - CLL Support
ASH 2013: Dr. Byrd Discusses Dinaciclib and the Need for More New Drugs to Treat CLL
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
ASH 2014. Dr. Sharman discusses the biology of our CLL cells
Medical Director of the CLL Society
http://cllsociety.org
http://bkoffman.blogspot.com
iwCLL 2013: Dr. Sharman discusses why we feel so lousy, and much more.
go on from there.
Please seem my blog: http://bkoffman.blogspot.com
Parts 5-7 will follow in...
ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)
just posted on my blog http://bkoffman.blogspot.com , Dr. John Pagel out of the Hutch and I discuss...
Dr. O'Brien on how she treats CLL frontline and Dr. Pagel on new ways to block BTK
rapy-in-cll/
•At EHA 2019, Dr. Pagel discusses new ways being researched to block BTK in CLL...
My 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.
that I remain U-MRD4 in the peripheral blood- no CLL to be found. Read more here:...
Related Posts
Is It Time to Treat Your CLL? What You Need to Know
ASH 2012 Interview: Dr Jeff Sharman \"Why New CLL Treatments Supersede FCR\"
I am CLL patient previusly treate with FR. I need to be treated again. I need some advice please.
ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)- ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIB
